EN 
ES Rare and Orphan
Diseases Unit
Dedicated to facilitating access to innovative and highly specialized
therapies for patients with low-prevalence conditions
Access to innovative therapies
Our Rare and Orphan Diseases Unit is dedicated to facilitating access to innovative and highly specialized therapies for patients living with low-prevalence conditions, often without available treatment alternatives in the country.
Comprehensive Strategy for Rare Diseases
We focus on developing commercial and regulatory strategies for high clinical value molecules that address real needs within the Peruvian healthcare system. While many of these diseases appear during childhood, our approach is comprehensive and covers all age groups.
Our outlook includes the incorporation of new therapies from international laboratories committed to the treatment of rare and orphan diseases, meeting the highest quality standards.
Cutting-edge treatments
The unit focuses on next-generation products, including monoclonal antibodies and molecules developed with advanced biotechnology, aimed at conditions with high clinical and social impact. Our commitment is to ensure these treatments reach those who need them most, within a regulated, transparent, and constantly evolving framework. In the current context, where Peru has recently regulated the approach to rare diseases, this unit remains in continuous regulatory and technical updating, identifying opportunities to efficiently respond to current provisions and facilitate the entry of new therapies into the country.
Clear Advantages of Our Service
Access to
Therapies
The unit enables patients with rare diseases to access state-of-the-art treatments, even when no options are available locally.
Comprehensive
Strategies
Specific commercial and regulatory solutions are developed for high-value molecules, with a cross-cutting approach that spans all age groups and addresses the country’s real needs.
Regulatory
Compliance
We work with advanced biotechnology (such as monoclonal antibodies) within a regulated framework, staying up to date with Peruvian regulations to facilitate the safe entry of new therapies.
Would you like to learn more about our products?
Please fill out the form below with your information and your company's details. Then, if you wish, leave us a comment and click the 'Submit' button. You are important to us and will be attended to as soon as possible.